Opus Genetics (IRD) Other Non Operating Income (2010 - 2026)

Opus Genetics (IRD) has 12 years of Other Non Operating Income data on file, last reported at $844000.0 in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $844000.0, up 179.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 39.3% YoY), and the FY2025 annual result was $2.0 million, down 55.5% from the prior year.
• Other Non Operating Income advanced to $844000.0 in Q1 2026 per IRD's latest filing, from $703000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $2.8 million in Q4 2024 and troughed at -$82000.0 in Q1 2022.
• A 5-year average of $536823.5 and a median of $456000.0 in 2023 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2023: Other Non Operating Income tumbled 8300.0% in 2022, then soared 6414.29% in 2023.
• A 5-year view of Other Non Operating Income shows it stood at $46000.0 in 2022, then surged by 1232.61% to $613000.0 in 2023, then surged by 360.36% to $2.8 million in 2024, then plunged by 75.09% to $703000.0 in 2025, then climbed by 20.06% to $844000.0 in 2026.
• Business Quant data shows IRD's Other Non Operating Income at $844000.0 in Q1 2026, $703000.0 in Q4 2025, and $450000.0 in Q3 2025.